Historical record - last NADAC effective date: 5/19/2021
Product Information
QUINAPRIL 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1123 per EA under NDC 69097083905. Its NADAC has been published 236 times since Nov 23, 2016.
FDA first approved this application on Aug 24, 2007.
Strength
5 mg/1
Manufacturer
Cipla USA Inc.NDC
69097083905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/19/2021
Active Ingredients
QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078457FDA Approved
8/24/2007
On Market Since
7/22/2016
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL 5 MG TABLET has been published 236 times since Nov 23, 2016, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1123 per EA |
|---|---|
| All-time high | $0.1585 (Nov 15, 2017) |
| All-time low | $0.0806 (Apr 21, 2021) |
| Median price | $0.1221 |
| Average price | $0.1215 |
| Largest weekly change | +45.4% (Jan 20, 2021) |
| Weeks tracked | 236 |
| Tracking since | Nov 23, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-18.8%
Last surveyed May 26, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Quinapril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of QUINAPRIL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL 5 MG TABLET, manufactured by Cipla USA Inc., is $0.1123 per EA (NDC 69097083905), effective May 26, 2021.
How has the price of QUINAPRIL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUINAPRIL 5 MG TABLET has declined 18.8%. It has been tracked across 236 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for QUINAPRIL 5 MG TABLET?
Since Nov 23, 2016, the NADAC for QUINAPRIL 5 MG TABLET has ranged from a low of $0.0806 (Apr 21, 2021) to a high of $0.1585 (Nov 15, 2017), with a median of $0.1221 per EA.
Are there cheaper alternatives to QUINAPRIL 5 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUINAPRIL 5 MG TABLET, is $0.0753 per EA — about 33% below QUINAPRIL 5 MG TABLET.
Who manufactures QUINAPRIL 5 MG TABLET?
QUINAPRIL 5 MG TABLET (NDC 69097083905) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.